Trial Profile
A randomized controlled trial of adalimumab injection compared with placebo for patients receiving physiotherapy treatment for sciatica
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 06 Sep 2021
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Sciatica
- Focus Therapeutic Use
- Acronyms SCIATiC
- 06 Aug 2018 Status changed from active, no longer recruiting to discontinued.
- 13 Feb 2015 New trial record
- 15 Dec 2014 Status changed from not yet recruiting to recruiting as per ISRCTN: Current Controlled Trials.